Add BrightSurf on Google Email

Dose-finding trial paves way for new rotavirus vaccine to prevent a deadly diarrheal disease from birth

A phase 2 clinical trial found that the Australian-developed neonatal rotavirus vaccine RV3-BB was safe and produced a robust immune response in African babies. The reduced dose of the vaccine generated an equivalent immune response as the highest dose, offering opportunities to reduce vaccine manufacturing costs.

SourceMurdoch Childrens Research Institute·JournalThe Lancet Infectious Diseases·TypeRandomized controlled/clinical trial·DateFeb 3, 2022
Creality K1 Max 3D Printer

Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.

NRG oncology trial results indicate trametinib should represent the new standard of care for women with recurrent low-grade serous ovarian cancer

The NRG-GOG 0281/LOGS trial demonstrated that trametinib significantly reduces disease progression and improves response rates in women with recurrent low-grade serous carcinoma of the ovary/peritoneum. The study found a trend towards higher overall survival rates when compared to standard of care options.

SourceNRG Oncology·JournalThe Lancet·DateFeb 3, 2022

Study of Penn patients with decade-long leukemia remissions after Car T cell therapy reveals new details about persistence of personalized “living drug” cells

Researchers discovered two patients with CAR T cell therapy achieved the longest-known remission to date, providing new details about treatment effects and outcomes. The study shows that the infused CAR T cells remained detectable for at least a decade, with sustained remission in both patients.

SourceUniversity of Pennsylvania School of Medicine·JournalNature·TypeData/statistical analysis·DateFeb 2, 2022
AmScope B120C-5M Compound Microscope

AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.

Promising treatment for deadly brain cancer

A clinical trial has found selinexor to be effective in shrinking tumors in almost a third of patients with recurrent glioblastoma, an aggressive brain cancer. The treatment induced responses in certain patients and allowed some to stay on the medication for over 12 months.

SourceColumbia University Irving Medical Center·JournalClinical Cancer Research·TypeRandomized controlled/clinical trial·DateFeb 1, 2022

Dartmouth study assesses how consumers interpret and act on results from at-home COVID-19 self tests

A Dartmouth study reveals that consumers using at-home COVID-19 self tests may misinterpret the implications of their test results, leading to either unnecessary or inadequate quarantine. The study suggests that individuals at high risk for infection should still quarantine after a negative test result.

SourceThe Geisel School of Medicine at Dartmouth·TypeRandomized controlled/clinical trial·DateJan 31, 2022
Apple AirPods Pro (2nd Generation, USB-C)

Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.

Hyperimmune intravenous immunoglobulin does not improve outcomes for adults hospitalized with COVID-19

A clinical trial found that combining remdesivir with hyperimmune intravenous immunoglobulin did not improve health status or safety for adults hospitalized with COVID-19. The trial also showed a higher risk of adverse outcomes among patients who generated SARS-CoV-2-neutralizing antibodies before treatment.

SourceNIH/National Institute of Allergy and Infectious Diseases·JournalThe Lancet·DateJan 27, 2022

Starting physical activity three days post-concussion is safe, has better outcomes

A new study published in the British Journal of Sports Medicine found that resuming non-contact physical activity 72 hours after a concussion is safe for children and youth. The study, which involved 456 participants, showed that early return to physical activity can reduce symptoms and delayed recovery.

SourceUniversity of Ottawa·JournalBritish Journal of Sports Medicine·TypeRandomized controlled/clinical trial·DateJan 26, 2022
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Fat injections could treat common cause of foot pain

A novel technique transplants patient fat into the sole to reduce plantar fasciitis symptoms, improving quality of life and sports activities. The study laid groundwork for a larger clinical trial with promising results.

SourceUniversity of Pittsburgh·JournalPlastic & Reconstructive Surgery·TypeRandomized controlled/clinical trial·DateJan 25, 2022

Children’s Hospital Colorado study explores methods to help reduce injury following successful post-concussion return-to-play

A Children's Hospital Colorado study explores a neuromuscular training intervention to reduce injury risk in athletes returning from sports-related concussions. The research found that athletes who completed the 8-week training program had a significantly lower risk of time-loss injuries compared to those who did not participate.

SourceChildren's Hospital Colorado·JournalThe American Journal of Sports Medicine·TypeRandomized controlled/clinical trial·DateJan 21, 2022
Celestron NexStar 8SE Computerized Telescope

Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.

Trastuzumab with chemoradiation and surgery does not improve outcomes for esophageal cancer patients, trial highlights future research opportunities

The NRG-RTOG 1010 clinical trial found that adding trastuzumab to chemoradiation and surgery did not improve disease-free survival for HER2-positive esophageal adenocarcinoma patients. Despite this, the study highlights future research opportunities to explore combining trastuzumab with other HER2-targeting agents.

SourceNRG Oncology·JournalThe Lancet Oncology·DateJan 21, 2022

NIH awards $170 million for precision nutrition study

The NIH is awarding $170 million to clinics and centers for a precision nutrition study that will develop algorithms to predict individual responses to food and dietary routines. The Nutrition for Precision Health study will recruit 10,000 participants from the All of Us Research Program.

SourceNIH/All of Us Research Program·DateJan 20, 2022
Apple MacBook Pro 14-inch (M4 Pro)

Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.

Review reports improved transparency in antidepressant drug trials

A new review and meta-analysis found that drug companies are increasingly disclosing negative study findings for antidepressants. While progress has been made, full transparency remains an issue, with researchers emphasizing the need to report all trial results, both positive and negative, to inform patient treatment.

SourceOregon Health & Science University·JournalPLOS Medicine·TypeLiterature review·DateJan 19, 2022

Spinocerebellar ataxia type 2: a therapeutic trial opens new avenues

A recent clinical trial conducted by Prof. Alexandra Durr's team found that riluzole does not improve symptoms in patients with spinocerebellar ataxia type 2, but provided valuable biomarkers for future trials. The study involved 45 patients and revealed a good tolerance and absence of adverse effects.

SourceInstitut du Cerveau (Paris Brain Institute)·JournalThe Lancet Neurology·TypeRandomized controlled/clinical trial·DateJan 19, 2022

Researchers show increased survival rate in prostate cancer patients with addition of hormone therapy treatments

A meta-analysis published in The Lancet Oncology reveals that men with intermediate- and high-risk prostate cancer experience improved overall survival with the addition of hormone therapy to radiotherapy. The study found prolonged adjuvant hormone therapy benefits men, while neoadjuvant hormone therapy did not.

SourceUniversity Hospitals Cleveland Medical Center·JournalThe Lancet Oncology·TypeMeta-analysis·DateJan 18, 2022

New COVID-19 drug passes phase 2 clinical trial

CERC-002, a cytokine neutralizer, has been shown to improve survival rates by 83.9% among hospitalized COVID patients compared to 64.5% with placebo. The treatment targets the immune response early on, preventing disease progression.

SourceSanford Burnham Prebys·JournalJournal of Clinical Investigation·DateJan 18, 2022
Apple Watch Series 11 (GPS, 46mm)

Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.

Ketamine and psychological therapy helped severe alcoholics abstain for longer in trial

A clinical trial found that people with severe alcohol disorder stayed off alcohol for longer when treated with low doses of ketamine combined with psychological therapy. The therapy showed promise in preventing relapse and improving liver function, with participants having lower depression rates after three months.

SourceUniversity of Exeter·JournalFrontiers in Psychiatry·TypeRandomized controlled/clinical trial·DateJan 11, 2022

NRG Oncology trial data concludes paclitaxel and carboplatin should be considered the standard of care as first-line treatment for women with uterine carcinosarcoma

The NRG Oncology GOG 0261 trial demonstrated that paclitaxel and carboplatin is a non-inferior alternative to paclitaxel and ifosfamide for treating women with uterine carcinosarcoma. This regimen offers improved progression-free survival and overall survival compared to the current standard of care.

SourceNRG Oncology·JournalJournal of Clinical Oncology·DateJan 11, 2022
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

New graft strategy may improve outcomes for blood stem cell recipients

A new graft strategy has reduced chronic graft-versus-host disease in leukemia patients by depleting naïve T cells from donor blood. The approach has shown promising results, with only 7% of patients developing chronic GVHD compared to 30-60% with standard treatment.

SourceUniversity of Pittsburgh·JournalJournal of Clinical Oncology·TypeRandomized controlled/clinical trial·DateJan 10, 2022

New: COVAX results

A registry study found that people with inflammatory RMDs, such as rheumatoid arthritis and psoriatic arthritis, tolerate their COVID vaccine well, with short-lived reactions being the most common side effect. The majority of participants were able to continue on their normal medication with no changes.

SourceEuropean Alliance of Associations for Rheumatology (EULAR)·JournalAnnals of the Rheumatic Diseases·DateJan 7, 2022

EBMT trial demonstrates improvements in immunosuppressive treatment of patients with Severe Aplastic Anemia

A phase III trial demonstrated that combining Eltrombopag with standard immunosuppression increases response rates and reduces time to first response in patients with Severe Aplastic Anemia. The treatment was found to be safe and well-tolerated, with improved event-free survival.

SourceEuropean Society for Blood and Marrow Transplantation·JournalNew England Journal of Medicine·DateJan 5, 2022

Relatlimab plus nivolumab improves progression-free survival in metastatic melanoma

The combination of relatlimab and nivolumab doubled progression-free survival benefit compared to nivolumab alone, with significant benefits across pre-specified subgroups. The treatment was associated with a lower risk of disease progression or death.

SourceUniversity of Texas M. D. Anderson Cancer Center·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateJan 5, 2022
Sony Alpha a7 IV (Body Only)

Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.

Researchers urge: ‘Prescribe aspirin based on benefit-to-risk not age’

Aspirin use in primary prevention of cardiovascular disease should be individualized based on benefit-to-risk assessment, not age. The authors' updated meta-analysis shows a 13% reduction in cardiovascular disease with similar benefits at older ages.

SourceFlorida Atlantic University·JournalFamily Medicine and Community Health·TypeMeta-analysis·DateJan 5, 2022

Comparing response to radiation therapy for prostate cancer in Black, White men

The study combined seven randomized clinical trials with 8,000 patients to compare overall and treatment-specific outcomes of Black and white men with localized prostate cancer who received radiation therapy. The results showed that there were significant racial disparities in response to radiation therapy for prostate cancer.

SourceJAMA Network·JournalJAMA Network Open·DateDec 29, 2021
Sky & Telescope Pocket Sky Atlas, 2nd Edition

Sky & Telescope Pocket Sky Atlas, 2nd Edition is a durable star atlas for planning sessions, identifying targets, and teaching celestial navigation.

The Lancet: Phase 3 trial reports one dose of Ad5-nCoV COVID-19 vaccine is safe and effective, including against severe disease

A phase 3 trial has shown that one dose of the Ad5-nCoV COVID-19 vaccine is highly effective against severe disease, with an efficacy rate of 91.7% at 28 days post-vaccination. The vaccine has also been found to be safe, with no serious vaccine-related adverse events or deaths reported among trial participants.

SourceThe Lancet·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateDec 23, 2021

Alternative statistical method could improve clinical trials

Researchers have developed a new statistical toolkit using the fragility index to determine if clinical trial results are strong and reliable. The new method has been shown to be more flexible than previous versions, allowing researchers to test assumptions and consider implications of a wider range of outcomes.

SourceCornell University·JournalProceedings of the National Academy of Sciences·DateDec 21, 2021

China-wide study will boost understanding of fatal surgical complication

A recent China-wide study investigated the effect of general versus regional anesthesia on post-operative delirium in older adults undergoing hip fracture surgery. The results showed no significant difference in delirium incidence between the two groups, contradicting previous assumptions.

SourceUniversity of Birmingham·JournalJAMA·TypeRandomized controlled/clinical trial·DateDec 21, 2021

A new post-surgery approach for treating HPV-related throat cancer uses less radiation safely and spares the majority of patients from chemotherapy

A new post-surgery approach for treating HPV-related throat cancer uses low-dose radiation and spares the majority of patients from chemotherapy. The trial found high survival rates and quality of life in patients at medium risk for recurrence.

SourceECOG-ACRIN Cancer Research Group·JournalJournal of Clinical Oncology·TypeRandomized controlled/clinical trial·DateDec 21, 2021
CalDigit TS4 Thunderbolt 4 Dock

CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.

New Alzheimer’s prevention trial in young people

A new clinical trial is enrolling young people with rare genetic mutations that cause early-onset Alzheimer's disease. The study will test gantenerumab to prevent the buildup of toxic protein amyloid beta, which can slow or stop the disease.

SourceWashU Medicine·DateDec 21, 2021

mRNA vaccines highly effective at preventing death from COVID-19, less effective at preventing infection

Researchers found that mRNA vaccines were highly effective (86%) in preventing SARS-CoV-2-related deaths among vaccinated individuals, especially in the elderly population. However, vaccine effectiveness against infection was lower (69%) and decreased with increasing age and comorbidity burden.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeRandomized controlled/clinical trial·DateDec 20, 2021
GQ GMC-500Plus Geiger Counter

GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.

Lundquist Institute investigator helps chart progress in clinical trial of patients with chemoresistant triple-negative breast cancer

A phase 1/2 clinical trial tested an L-NMMA and taxane combination in patients with chemoresistant TNBC, showing a remodeling of the immune environment in responders. The study's results warrant further investigation in larger trials to identify potential biomarkers for predicting response.

SourceThe Lundquist Institute·JournalScience Translational Medicine·TypeRandomized controlled/clinical trial·DateDec 15, 2021
Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C)

Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C) keeps Macs, tablets, and meters powered during extended observing runs and remote surveys.

New research in JNCCN raises concerns about clinical trial bias from undisclosed censoring

A recent study published in JNCCN found that 33 out of 81 studies lacked transparency on censoring, which can introduce bias and affect trial results. The researchers emphasize the need for improved transparency and reporting in clinical trials to ensure patients and clinicians make informed decisions.

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·DateDec 15, 2021

KEYNOTE-811: Pembrolizumab combination as a potentially transformative treatment for HER2-positive gastric cancer

The KEYNOTE-811 trial demonstrates a significant improvement in objective response rate (74.4%) and tumor size reduction compared to trastuzumab and chemotherapy. The combination of pembrolizumab, trastuzumab, and chemotherapy markedly reduces tumor size and induces complete responses in some patients.

SourceVall d'Hebron Institute of Oncology·JournalNature·TypeRandomized controlled/clinical trial·DateDec 15, 2021

High pressure (hyperbaric) oxygen resolves severe COVID-19 breathing difficulties faster than standard therapy

A small clinical trial found that high-pressure hyperbaric oxygen treatment resolved severe COVID-19 breathing difficulties faster than standard therapy, with significant improvements in oxygen saturation and reduced risk of complications. However, further larger trials are needed to confirm the treatment's effects on survival.

SourceBMJ Group·JournalEmergency Medicine Journal·TypeRandomized controlled/clinical trial·DateDec 14, 2021
Sky-Watcher EQ6-R Pro Equatorial Mount

Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.

New treatment combination without chemotherapy is effective in PH+ acute lymphoblastic leukemia

A new treatment combination of dasatinib, blinatumomab, and prednisone has shown promise in treating older patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia. The trial achieved a three-year DFS rate of 80 percent and an overall survival rate of 85 percent for enrolled patients.

SourceSWOG Cancer Research Network·TypeRandomized controlled/clinical trial·DateDec 13, 2021

Protein in blood sign of heart damage after surgery

Researchers found that up to one in five patients experience increased troponin levels after major surgery, indicating potential heart damage. These patients were also more likely to be anaemic before the operation.

SourceLinköping University·JournalBritish Journal of Anaesthesia·TypeObservational study·DateDec 13, 2021

Moffitt study shows lymphoma patients can benefit from receiving CAR T sooner

A new study published in the New England Journal of Medicine found that using CAR T therapy as a second-line treatment provided better outcomes compared to standard care in patients with diffuse large B-cell lymphoma. The two-year follow-up data showed a median event-free survival of 8.3 months in the CAR T arm versus 2 months in the s...

SourceH. Lee Moffitt Cancer Center & Research Institute·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateDec 11, 2021
Garmin GPSMAP 67i with inReach

Garmin GPSMAP 67i with inReach provides rugged GNSS navigation, satellite messaging, and SOS for backcountry geology and climate field teams.

Potentially serious side effect seen in patient after immunotherapy

A case study published in Nature Medicine reports a patient experiencing progressive neurological features resembling Parkinson's disease after CAR-T cell therapy, suggesting potential neurotoxicity. The study highlights the importance of monitoring for neurotoxicity in patients receiving BCMA-targeted CAR-T therapies.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature Medicine·DateDec 10, 2021

SET2,3 index can be prognostic in HR+ breast cancer, independent of recurrence score

Researchers discovered that the SET2,3 index provides complementary prognostic information about breast cancer outcomes, particularly for patients with hormone receptor-positive breast cancer. The study suggests that using both clinical and molecular information from a patient's tumor can guide treatment decision-making.

SourceSWOG Cancer Research Network·TypeData/statistical analysis·DateDec 9, 2021
DJI Air 3 (RC-N2)

DJI Air 3 (RC-N2) captures 4K mapping passes and environmental surveys with dual cameras, long flight time, and omnidirectional obstacle sensing.